Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 9;6(1):11-16.
doi: 10.1002/mdc3.12687. eCollection 2019 Jan.

22q11.2 Deletion Syndrome-Associated Parkinson's Disease

Erik Boot  1   2   3 , Anne S Bassett  1   4   5   6 , Connie Marras  7   8
Affiliations
Review

22q11.2 Deletion Syndrome-Associated Parkinson's Disease

Erik Boot et al. Mov Disord Clin Pract. .

Abstract

Background: 22q11.2 deletion syndrome (22q11.2DS) is a multisystem condition associated with an increased risk of early-onset Parkinson's disease (PD).

Methods: We review the clinical, neuroimaging, and neuropathological observations, as well as diagnostic challenges, of PD in 22q11.2DS. We conducted a search of PubMed up until June 1, 2018 and personal files to identify relevant publications.

Results: 22q11.2DS-associated PD is responsible for approximately 0.5% of early-onset PD. The hallmark motor symptoms and neuropathology of PD, and typical findings of reduced striatal dopamine transporter binding with molecular imaging, are present in 22q11.2DS-associated PD. Mean age at PD onset in 22q11.2DS is relatively young (∼40 years). Patients with 22q11.2DS-associated PD show a good response to levodopa.

Conclusions: Further recognition of 22q11.2DS and study of PD in people with 22q11.2DS could provide insights into the mechanisms that cause PD in the general population. 22q11.2DS may serve as an identifiable PD model to study prodromal PD and disease-modifying treatments.

Keywords: 22q11 deletion syndrome; Parkinson's disease; movement disorders; neurodegeneration; parkinsonism.

PubMed Disclaimer

References

    1. Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers 2017;3:17013. - PubMed
    1. McDonald‐McGinn DM, Sullivan KE, Marino B, et al. 22q11.2 deletion syndrome. Nat Rev Dis Primers 2015;1:15071. - PMC - PubMed
    1. Mok KY, Sheerin U, Simon‐Sanchez J, et al. Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome‐wide association data. Lancet Neurol 2016;15:585–596. - PMC - PubMed
    1. Butcher NJ, Kiehl TR, Hazrati LN, et al. Association between early‐onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol 2013;70:1359–1366. - PMC - PubMed
    1. Bassett AS, McDonald‐McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011;159:332–339. - PMC - PubMed

LinkOut - more resources